Li et al. showed that polyethylene glycolated (PEGylated) 17i nanoassemblies were superior to the KDM1A inhibitor compound 17i in terms of therapeutic efficiency, anti-tumor immune response, and systemic toxicity in xenografted CRC mice [182]. This evidence concerns the gene KDM1A and neoplasm.